Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis - PubMed (original) (raw)

Review

Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis

Whitney Stevens et al. Curr Allergy Asthma Rep. 2015 Dec.

Abstract

Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis. While each disease subtype may be distinguished by unique clinical features, the underlying mechanisms that contribute to these phenotypes are not fully understood. However, the inhibition of the cyclooxygenase-1 enzyme is thought to play a significant role. Additionally, eosinophils, mast cells, and their products, prostaglandins and leukotrienes, have been identified in the pathogenesis of AERD. Current diagnostic and treatment strategies for aspirin-exacerbated diseases remain limited, and continued research focusing on each of the unique hypersensitivity reactions to aspirin is essential. This will not only advance the understanding of these disease processes, but also lead to the subsequent development of novel therapeutics that patients who suffer from aspirin-induced reactions desperately need.

Keywords: Anaphylaxis; Angioedema; Aspirin hypersensitivity; Aspirin-exacerbated respiratory disease (AERD); Nasal polyposis; Urticaria.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Allergy Clin Immunol. 2013 Oct;132(4):856-65.e1-3 - PubMed
    1. Exp Lung Res. 2014 Dec;40(10):485-94 - PubMed
    1. Clin Gastroenterol Hepatol. 2011 Sep;9(9):762-768.e6 - PubMed
    1. PLoS One. 2014 Dec 23;9(12):e111220 - PubMed
    1. J Allergy Clin Immunol. 2008 Jan;121(1):81-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources